MCI

(redirected from Mild cognitive impairment)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Acronyms, Wikipedia.

MCI

(company)
A United States long-distance telecommunications company. Recently bought from British Telecom

MCI

(1) (Media Control Interface) A high-level programming interface from Microsoft and IBM for controlling multimedia devices. It provides commands and functions to open, play and close the device.

(2) (Microwave Communications Inc.) The long distance telephone company that was largely responsible for competitive telephone services in the U.S. It all started in 1963 in Springfield, IL. Jack Goeken and four others formed a company to increase sales of two-way radios by building microwave towers along Route 66 from St. Louis to Chicago for truckers. Bill McGowan, a New York consultant, joined the company in 1968 and helped Goeken acquire leases to build towers nationwide at a time when AT&T controlled virtually all long distance in the U.S.

In 1969, the FCC granted MCI the right to offer long distance services and to hook up to AT&T's network for access to the customer's premises, yet MCI was thwarted at every turn. In 1974, it filed a suit against AT&T, and the Justice Department filed its own suit, all of which led to the breakup of AT&T in 1984 (see Divestiture).

Throughout the 1980s and 1990s, MCI raised USD $2.6 billion in capital, offered innovative services and ultimately captured one third of the business market. After McGowan died in 1992, MCI lost its soul and was slower to form novel strategies; however, it did develop one of the best IP networks in the country. In 1997, MCI was acquired by WorldCom for $30 billion. Five years later, WorldCom declared bankruptcy, but emerged in 2004 as MCI.

In 2005, MCI was acquired by Verizon Communications, Inc. and became the Verizon business division of the company (www.verizonbusiness.com). See WorldCom and MCI Decision.
References in periodicals archive ?
Companies mentioned in this Mild Cognitive Impairment pipeline H2 2015 review report include Actinogen Limited, Avraham Pharmaceuticals Ltd.
Professor Tales said of the project: "We expect the outcome of this research study to increase our understanding of vascularrelated mild cognitive impairment and vascular dementia and to have a direct, positive influence on the development of reallife and clinically-relevant tests of brain function, such as those used for early diagnosis and for guiding management.
Major finding: For patients with mild cognitive impairment, every 1% increase in the rate of whole brain atrophy during a single year was associated with a 1.
9 times more likely to develop mild cognitive impairment than those with the lowest intake of carbohydrates.
The finding that the frequency of mild cognitive impairment is greater in men was unexpected, since the frequency of Alzheimer's disease is actually greater in women.
Besides men in general, subjects found to be at higher risk for mild cognitive impairment included those who had never been married, those with less than nine years of schooling and those carrying the ApoE4 gene, which is a risk factor for late-onset Alzheimer's.
Dr Susanne Sorensen, head of research at the Alzheimer's Society, said: "Increasing our understanding of mild cognitive impairment could help us unravel the many mysteries still surrounding Alzheimer's disease and move us closer to treatments and a cure.
But moderate alcohol consumption doesn't improve thinking processes in those who already have mild cognitive impairment (MCI), and heavy drinking can tip the scales from mild impairment to dementia, Dr.
Repeated concussions brought on by blows to the head during their playing days significantly boost the chances that retired professional football players will suffer dementias such as mild cognitive impairment in later life, suggests a study by the University of North Carolina, Chapel Hill.
Patients with mild cognitive impairment have memory loss, but do not have difficulty paying attention and do not experience confusion.
Vitamin E failed to slow the progression to Alzheimer's disease in a study of more than 700 Americans and Canadians with mild cognitive impairment.
The inability to smell certain odours can determine which patients with minimal or mild cognitive impairment will go on to develop Alzheimer's, the researchers said.